{"acquisitions":[],"changes":[],"country":"US","description":"Clinical-stage biotech developing antithrombotic biologics including AB023 and rZPI for thrombosis without bleeding-risk side effects. Targets pharma partners and patients needing safer anticoagulation in surgery, dialysis, and post-stroke care. Differentiates by targeting contact pathway proteins so patients get clot prevention without classical bleeding risk.","domain":"aronorabio.com","employees":null,"founded":2008,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":45.520247,"lng":-122.674194,"location":"PORTLAND, Oregon, USA","multiples":[],"name":"ARONORA INC","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":2800000,"connectionsAmong":[],"currency":"USD","date":"2024-07-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"aronorabio-com-2024-07-01-grant","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"aronorabio-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"aronorabio.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://aronorabio.com"},{"fact":"description","publisher":"aronorabio.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://aronorabio.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","WordPress","Yoast SEO 27.5","reCAPTCHA","Google Analytics","Google Tag Manager","jQuery Migrate","PHP","DoubleClick Floodlight","Cloudflare Bot Management","WP Engine","WP Rocket 3.21.2"],"totalRaisedUsd":2811912,"traction":[],"updatedAt":"2026-05-05","valuations":[]}